Jane Street Group, LLC Nova Bay Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.11 - $147.37 $728 - $976,326	6,625 Added 50.65%	19,706 $2,000
Q2 2022 Aug 16, 2022	BUY	$0.18 - $0.31 $2,354 - $4,055	13,081 New	13,081 $3,000
Q4 2021 Feb 15, 2022	SELL	$0.38 - $0.61 $16,520 - $26,519	-43,474 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$0.58 - $0.69 $25,214 - $29,997	43,474 New	43,474 $28,000
Q3 2019 Nov 14, 2019	SELL	$0.45 - $1.73 $16,779 - $64,506	-37,287 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$0.28 - $3.1 $10,440 - $115,589	37,287 New	37,287 $63,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $46.1M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.